Application YC di 20n
20n ha partecipato a Y Combinator nel batch Winter 2015 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Winter 2015
- Settore
- HealthcareIndustrial Bio
- Dimensione team
- 2
- Stato
- Inactive
- Lanciata
- 2014
Founder
Saurabh SrivastavaFounder/CEO
Chris AndersonFounder/CSO
Cosa fa 20n
The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing and synthesis being mainstream now [1], 20n provides the computational systems that predict DNA design for novel industrial biotech and health applications. At 20n, we are taking a fresh look at turning biological data into information. We approach it as a big data learning problem, and bring to bear techniques from machine learning, distributed systems, AI planning, program synthesis, data mining, and natural language processing. With the support of DARPA [2], we are building a team of computer scientists, and bioengineers to look at biology in fundamentally new ways. Our current customers include industrial biotech firms that are leading the charge in transitioning us from traditional unsustainable means of manufacturing to sustainable biological processes leading to advanced fuels, materials, therapeutics, and flavors and fragrances. 20n’s technology helps them enter markets previously thought inaccessible for biology. [1] Sequencing DNA costs $4k/genome ( and is expected to go down to $1k/genome. Synthesizing DNA is at 20cents/bp, and is expected to go down to 0.1cents/bp. [2] DARPA in the past supported work that led to the internet, stealth planes, GPS, and even Douglas Engelbart’s mother-of-all-demos.
Application YC di 20n, ricostruita
Domanda per Y Combinator
20n, batch Winter 2015. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
20n
Using AI to predict biochemistry for manufacturing
We are building computational systems that use AI and machine learning to predict DNA designs for industrial biotech and therapeutics. Our product helps industrial biotech firms design biological systems that can produce fuels, materials, flavors, and medicines that were previously inaccessible by traditional methods.
We live in San Francisco, CA, and would base the company here after YC.
San Francisco has the technical talent and biotech ecosystem we need to grow. It keeps us close to early industrial biotech customers and partners.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di 20n?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di 20n (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come 20n si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva 20n?
20n apparteneva al batch Winter 2015 di Y Combinator.
Chi ha fondato 20n?
20n è stato fondato da Saurabh Srivastava, Chris Anderson.
Cosa fa 20n?
Using AI to predict biochemistry for manufacturing and therapeutics
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di 20n, e di ogni altro batch YC, è in YC Insights.
Più startup YC come 20n
